Analyst Reaffirms Buy Rating and 120 Price Target for Viking Therapeutics
Maxim Group analyst Naz Rahman has once again expressed optimism in Viking Therapeutics (NASDAQ: VKTX), reiterating a Buy rating and ...
Maxim Group analyst Naz Rahman has once again expressed optimism in Viking Therapeutics (NASDAQ: VKTX), reiterating a Buy rating and ...
Viking Therapeutics (VKTX) stock has been on a rollercoaster ride, dropping by 10.9% on a recent Monday afternoon. This dip ...
StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.